Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | PDE2A | O00408 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28506559 | 0.97 | CYP1A2 (0.47) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL3109540 | 0.87 | ALDH1A1 (0.42) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL4570474 | 0.85 | ALDH1A1 (0.46) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL2633440 | 0.84 | ALDH1A1 (0.44) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL16329868 | 0.80 | ALDH1A1 (0.37) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6335607 | 0.79 | L3MBTL1 (0.37) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6337444 | 0.79 | PDGFRB (0.44) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL28047971 | 0.78 | ALDH1A1 (0.52) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL6806147 | 0.77 | LMNA (0.53) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL13729689 | 0.77 | NNMT (0.50) | CYP1A2LMNASMN1; SMN2KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100210467-A1 | AGENT FOR IMPROVING SUGARCANE BRIX AND METHOD OF PROMOTING SUGARCANE RIPENING USING THE SAME | KUMIAI CHEMICAL INDUSTRY CO., LTD. | 2010-08-19 | — | — | US | claimed |
| EP-0507962-B1 | PICOLINIC ACID DERIVATIVE, PRODUCTION THEREOF, AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2001-06-13 | — | — | EP | claimed |
| EP-0671880-A1 | SELECTIVE HERBICIDAL COMPOSITION | CIBA-GEIGY AG (CH) | 1995-09-20 | — | — | EP | claimed |
| US-5391537-A | Picolinic acid derivative, and herbicidal composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-02-21 | — | — | US | claimed |
| WO-1994000987-A2 | SELECTIVE HERBICIDAL COMPOSITION | CIBA-GEIGY AG (CH) | 1994-01-20 | — | — | WO | claimed |
| EP-0507962-A1 | PICOLINIC ACID DERIVATIVE, PRODUCTION THEREOF, AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-10-14 | — | — | EP | claimed |
| CN-110959138-B | Resist material | DIC株式会社 | 2023-06-30 | — | — | CN | disclosed |
| US-11487204-B2 | Resist material | DIC CORPORATION (JP) | 2022-11-01 | — | — | US | disclosed |
| EP-3153023-B1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | TAKEDA PHARMACEUTICALS CO (JP) | 2022-03-16 | — | — | EP | disclosed |
| US-20210253566-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-08-19 | — | — | US | disclosed |
| CN-112961149-A | Cytochrome P450 inhibitors and uses thereof | 安吉恩生物医药公司 | 2021-06-15 | — | — | CN | disclosed |
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-06-10 | — | — | US | disclosed |
| EP-3180335-B1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2021-05-05 | — | — | EP | disclosed |
| US-5202329-A | Pyrimidinyloxy(thio)quinoline derivative, and agri-horticultural fungicide comprising the derivative as active ingredient | MITSUI TOATSU CHEMICALS INC. (JP) | 1993-04-13 | — | — | US | disclosed |
| EP-0532761-A1 | PYRIDINE DERIVATIVE, PRODUCTION THEREOF, HERBICIDE AND METHOD OF WEEDING | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1993-03-24 | — | — | EP | disclosed |
| EP-0507962-A1 | PICOLINIC ACID DERIVATIVE, PRODUCTION THEREOF, AND HERBICIDE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-10-14 | — | — | EP | disclosed |
| EP-0497371-A1 | Pyrimidinyloxy(thio)quinoline derivatives, preparation process of the derivative, and agri-horticultural fungicide comprising the derivative as active ingredient | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-08-05 | — | — | EP | disclosed |
| US-5087289-A | ALKANOIC ACID DERIVATIVES AND HERBICIDAL COMPOSITIONS | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1992-02-11 | — | — | US | disclosed |
| US-4968340-A | PREEMERGENCE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1990-11-06 | — | — | US | disclosed |
| EP-0347811-A1 | Alkanoic acid derivatives and herbicidal compositions | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1989-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | CYP7A1, CYP2E1, CYP11B1 | CYP1A2 4/4885LMNA 2070/4885SMN1; SMN2 3698/4885 |
| US-20210253566-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | CYP7A1, CYP2E1, CYP1A2 | CYP1A2 3/4885LMNA 2143/4885SMN1; SMN2 3732/4885 |
| US-11487204-B2 | Resist material | FLNA, AFF1, RXRA | CYP1A2 1595/4885LMNA 985/4885SMN1; SMN2 2194/4885 |
| US-20100210467-A1 | AGENT FOR IMPROVING SUGARCANE BRIX AND METHOD OF PROMOTING SUGARCANE RIPENING USING THE SAME | BRIX1, MGAM, MGAM2 | CYP1A2 3682/4885LMNA 3335/4885SMN1; SMN2 1337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.